Choose a date range

From To

Choose one or more categories


Show only original CenterWatch stories


All Party Parliamentary Group established to raise profile of U.K. life sciences sector

Wednesday, July 22, 2015 01:56 PM

The All Party Parliamentary Group (APPG) on Life Sciences has launched to raise awareness and understanding of the valuable contribution the life sciences sector provides to the health and the wealth of the U.K.

More... »

Quest Diagnostics

Emergent BioSolutions awarded $19.7M BARDA Ebola contract

Wednesday, July 22, 2015 01:49 PM

Emergent BioSolutions, a global specialty biopharmaceutical company based in Gaithersburg, Md., has been awarded a contract by the Biomedical Advanced Research and Development Authority (BARDA) valued at $19.7 million to develop and manufacture cGMP lots of three Ebola monoclonal antibodies in CHO cell lines at a 2000 liter scale.

More... »

NIH joins public-private partnership to fund research on autism biomarkers

Wednesday, July 22, 2015 01:43 PM

The NIH, the Foundation for the NIH (FNIH), the Simons Foundation Autism Research Initiative (SFARI) and others will fund a multiyear project to develop and improve clinical research tools for studying autism spectrum disorder (ASD).

More... »

Valeant Pharmaceuticals to acquire Amoun Pharmaceutical

Wednesday, July 22, 2015 01:41 PM

Valeant Pharmaceuticals International has entered into a definitive agreement to acquire Mercury (Cayman) Holdings, the holding company of Amoun Pharmaceutical, for approximately $800 million, plus contingent payments.

More... »

Aslan Pharmaceuticals, National Cancer Center Singapore collaborate

Wednesday, July 22, 2015 01:39 PM

Aslan Pharmaceuticals, an oncology focused biotechnology company, and National Cancer Center Singapore (NCCS) have signed a Memorandum of Understanding (MOU) that will further enhance the study of novel therapeutic agents for the treatment of gastric cancer, hepatocellular carcinoma (liver) and cholangiocarcinoma (bile duct), three common forms of gastrointestinal (GI) cancers that are particularly prevalent in Asia. 

More... »

Epic Sciences, LabCorp expand partnership in Asia

Wednesday, July 22, 2015 01:37 PM

Epic Sciences, a San Diego, Calif.-based developer of novel diagnostics to personalize and advance the treatment and management of cancer, has inked an agreement with Laboratory Corporation of America Holdings (LabCorp), a Burlington, N.C.-based healthcare diagnostics company, to provide circulating tumor cell (CTC) technology and support oncology clinical trials in Asia through Covance Drug Development.

More... »

Frontage Laboratories acquires BDM Consulting

Wednesday, July 22, 2015 01:35 PM

Frontage Laboratories, a full-service CRO based in Andover, Mass., has acquired BDM Consulting, of Summerset, N.J. The acquisition expands Frontage's current capabilities and strengthens its full-service drug and medical device development services across both North America and Asia.

More... »

Almac Group adds regional headquarters, trial supply facility in Singapore

Wednesday, July 22, 2015 01:34 PM

Almac Group, a global contract development and manufacturing organization, has successfully completed the Health Sciences Authority (HSA) inspection of their new Asia Pacific headquarters in Singapore.

More... »

Regulatory compliance is about to get more challenging in the E.U.

Monday, July 20, 2015 08:00 AM

Last year, the European Union (E.U.) adopted new clinical trial regulation, E.U. CTR 536/2014, which is intended to clarify and standardize rules for conducting clinical trials across the region.

More... »

Eisai to transfer Research Triangle Park campus to Biogen

Friday, July 17, 2015 11:51 AM

Eisai has entered into a definitive agreement to transfer ownership of its Research Triangle Park (RTP) manufacturing campus to Biogen. This arrangement expands upon the capacity-sharing manufacturing alliance Eisai and Biogen have had in place at the RTP facility since early 2013.

More... »


July 27

AB Science warned about putting study volunteers in danger

FDA, Google unite to detect search-data adverse events

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.


Featured Jobs